Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003CA2299959C Procedure for the preparation of dioxopenicillanic acid derivatives
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/13/2003CA2105979C Monoclonal antibody against lps core
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038032A2 Means for inhibition of the synthesis of viral proteins
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037902A1 Separation of regioisomers of metal phthalocyanines
05/08/2003WO2003037895A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037894A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037893A1 Acyl dihydro pyrrole derivatives as hcv inhibitors
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037866A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037860A2 Purine analogs having hsp90-inhibiting activity
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037845A1 Compositions for treating acne comprising phytandiol amine
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037382A1 Low concentration of peroxide for treating or preventing vaginal infections
05/08/2003WO2003037371A2 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
05/08/2003WO2003037370A2 Anthrax antigenic compositions
05/08/2003WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037358A1 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method
05/08/2003WO2003037356A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037312A2 Ribavirin syrup formulations
05/08/2003WO2003037311A2 Method for treating retroviral infections
05/08/2003WO2003037310A2 Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents
05/08/2003WO2003037304A1 Controlled release compositions for macrolide antimicrobial agents
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037262A2 Novel anit-infectives
05/08/2003WO2003037255A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003022192B1 Eustachian tube stent
05/08/2003WO2003012129A3 Shikimate kinase from s. aureus for drug discovery
05/08/2003WO2003006634A3 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002095023A3 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002088428A3 Electrolyser with anionic membrane and method for producing a hypochlorite solution using same
05/08/2003WO2002088124A3 Pyrazolo'1,5-a!pyridine derivatives
05/08/2003WO2002085283A3 Vaccine against tuberculosis
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002057226A3 68730 and 69112 protein kinase molecules and uses therefor
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003WO2002036110A3 Oral self-emulsifying formulations of pyranone protease inhibitors
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088092 Water-soluble porphyrin derivatives and methods of their preparation
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030088061 Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing an allosteric regulatory site
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087904 Xanthine derivatives, such as 3-isobutyl-8-pyrrolidinylxanthine; treating asthma, diarrhea, etc.
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087887 Gonane derivative antibiotics
05/08/2003US20030087880 Hydroxy-benzoic acid derivatives; bactericides
05/08/2003US20030087873 Treating a Flaviviridae, Orthomyxoviridae or Paramyxoviridae infection
05/08/2003US20030087846 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
05/08/2003US20030087844 Ribavirin syrup formulations
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087823 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof
05/08/2003US20030087818 Compositions and methods for the therapy and diagnosis of colon cancer
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087420 Transgenic animals and cells expressing proteins necessary for susceptibility to HIV infection
05/08/2003US20030087417 Newcastle disease virus infectious clones, vaccines and diagnostic assays
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087255 Peptides which stimulate the immune response and tissue regeneration
05/08/2003US20030087235 Diagnosing mammary gland cancer in humans; obtain target cells, obtain nucleotide sequences, screen for deletion of heterozygosity anf preferential chromosomal position, classify sample, loss of heterozygosity indicate tumor
05/08/2003US20030087230 L-Ribo-LNA analogues
05/08/2003US20030086992 Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
05/08/2003US20030086986 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086976 Pharmaceutical compositions for poorly soluble drugs
05/08/2003US20030086947 For diagnosis and prevention of ungulate diseases caused by treponeme spirochete bacteria
05/08/2003US20030086946 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
1 ... 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 ... 1798